Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats

Abstract

To evaluate the association between hypertension, male erectile function, Rho-kinase, and cyclic GMP pathways, we monitored neurogenic erectile response in spontaneously hypertensive (SHR) vs normotensive rats. We also evaluated SHR erectile function before and after intracavernosal injection of either the specific Rho-kinase inhibitor Y-27632 or a combination of Y-27632 and the PDE5 inhibitor zaprinast to prevent cGMP degradation. SHR had lower resting baseline corpus cavernosum pressure and a higher threshold for development of tumescence than normotensive rats. In SHR, Y-27632 administration reversed hypertension-related changes in male erectile function; Rho-kinase antagonism and PDE5 inhibition in combination had a synergistic effect in improving the neurogenic erectile response. Our data indicate that hypertension is associated with impairment in the SHR neurogenic erectile response that may involve a derangement in hemodynamic mechanisms in penile erectile tissue. Rho-kinase inhibition alone or combined with PDE5 inhibition may be of value in treating hypertension-related ED.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 7
Figure 6

Similar content being viewed by others

References

  1. Burchardt M et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.

    Article  CAS  Google Scholar 

  2. Jaffe A et al. Erectile dysfunction in hypertensive subjects. Assessment of potential determinants. Hypertension 1996; 28: 859–862.

    Article  CAS  Google Scholar 

  3. Muller SC, el-Damanhoury H, Ruth J, Lue TF . Hypertension and impotence. Eur Urol 1991; 19: 29–34.

    Article  CAS  Google Scholar 

  4. Fogari R, Zoppi A . Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Rep 2002; 4: 202–210.

    Article  Google Scholar 

  5. Taub HC, Lerner SE, Melman A, Christ GJ . Relationship between contraction and relaxation in human and rabbit corpus cavernosum. Urology 1993; 42: 698–704.

    Article  CAS  Google Scholar 

  6. Burnett AL . Role of nitric oxide in the physiology of erection. Biol Reprod 1995; 52: 485–489.

    Article  CAS  Google Scholar 

  7. Kloss S, Bouloumie A, Mulsch A . Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 2000; 35(1 Part 1): 43–47.

    Article  CAS  Google Scholar 

  8. Ruetten H, Zabel U, Linz W, Schmidt HH . Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 1999; 85: 534–541.

    Article  CAS  Google Scholar 

  9. Lopez-Farre A et al. Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the α1-receptor blocker doxazosin. J Hypertens 2002; 20: 463–470.

    Article  CAS  Google Scholar 

  10. Moreland RB, Hsieh G, Nakane M, Brioni JD . The biochemical and neurologic basis for the treatment of male erectile dysfunction. J Pharmacol Exp Ther 2001; 296: 225–234.

    CAS  PubMed  Google Scholar 

  11. Andersson KE . Pharmacology of penile erection. Pharmacol Rev 2001; 53: 417–450.

    CAS  PubMed  Google Scholar 

  12. Chitaley K et al. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 2001; 7: 119–122.

    Article  CAS  Google Scholar 

  13. Wang H et al. RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem 2002; 277: 30614–30621.

    Article  CAS  Google Scholar 

  14. Somlyo AP, Somlyo AV . Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000; 522 (Part 2): 177–185.

    Article  CAS  Google Scholar 

  15. Uehata M et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990–994.

    Article  CAS  Google Scholar 

  16. Mills TM, Chitaley K, Lewis RW, Webb RC . Nitric oxide inhibits RhoA/Rho-kinase signaling to cause penile erection. Eur J Pharmacol 2002; 439: 173–174.

    Article  CAS  Google Scholar 

  17. Sawada N et al. cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 2001; 280: 798–805.

    Article  CAS  Google Scholar 

  18. Sauzeau V et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits rhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000; 275: 21722–21729.

    Article  CAS  Google Scholar 

  19. Toblli JE et al. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000; 13: 686–692.

    Article  CAS  Google Scholar 

  20. Eto Y et al. Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. Am J Physiol Heart Circ Physiol 2000; 278: H1744–H1750.

    Article  CAS  Google Scholar 

  21. Masumoto A et al. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001; 38: 1307–1310.

    Article  CAS  Google Scholar 

  22. Sawada N et al. Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 2000; 101: 2030–2033.

    Article  CAS  Google Scholar 

  23. Mills TM et al. Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol 2001; 91: 1269–1273.

    Article  CAS  Google Scholar 

  24. Jensen J et al. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999; 12: 271–275.

    Article  CAS  Google Scholar 

  25. Clark JT, Sahu A, Mrotek JJ, Kalra SP . Sexual function and neuropeptide Y levels in selected brain regions in male spontaneously hypertensive rats. Am J Physiol 1991; 261 (5 Part 2): R1234–R1241.

    CAS  PubMed  Google Scholar 

  26. Okabe H et al. The penis is not protected—in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int J Impot Res 1999; 11: 133–140.

    Article  CAS  Google Scholar 

  27. Chitaley K, Webb RC, Dorrance AM, Mills TM . Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res 2001; 13 (Suppl 5): S16–S20.

    Article  Google Scholar 

  28. Behr-Roussel D et al. Erectile dysfunction in spontaneously hypertensive rats: patho-physiological mechanisms. Am J Physiol 2003; 284: R682–R688.

    CAS  Google Scholar 

  29. Mukai Y et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 2001; 15: 1062–1064.

    Article  CAS  Google Scholar 

  30. Chrissobolis S, Sobey CG . Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Circ Res 2001; 88: 774–779.

    Article  CAS  Google Scholar 

  31. Nehra A et al. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol 1998; 159: 2229–2236.

    Article  CAS  Google Scholar 

  32. Wespes E . Smooth muscle pathology and erectile dysfunction. Int J Impot Res 2002; 14 (Suppl 1): S17–S21.

    Article  Google Scholar 

  33. Kim NN et al. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Cell Mol Biol Res Commun 2000; 4: 10–14.

    Article  CAS  Google Scholar 

  34. Abdel-Latif AA . Cross talk between cyclic nucleotides and polyphosphoionositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp Biol Med 2001; 226: 153–163.

    Article  CAS  Google Scholar 

  35. Sakai J, Oike M, Hirakawa M, Ito Y . Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells. J Physiol 2003; 549: 171–180.

    Article  CAS  Google Scholar 

  36. Sauzeau V et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000; 275: 21722–21729.

    Article  CAS  Google Scholar 

  37. Jarow JP, Burnett AL, Geringer AM . Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999; 162: 722–725.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the American Foundation for Urologic Disease/American Urological Association summer scholarships awarded to Nathan Wilkes and Steven White. The authors wish to acknowledge Daniel Cosgrove for his technical support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Rajasekaran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilkes, N., White, S., Stein, P. et al. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats. Int J Impot Res 16, 187–194 (2004). https://doi.org/10.1038/sj.ijir.3901149

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901149

Keywords

This article is cited by

Search

Quick links